ijms-logo

Journal Browser

Journal Browser

Lipid and Metabolic Syndrome

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 4203

Special Issue Editor


E-Mail Website
Guest Editor
Department of Endocrinology and Metabolism, Asan Diabetes Center, University of Ulsan, Seoul, Republic of Korea
Interests: diabetes; obesity; metabolism; adipose tissue inflammation; adipocytokines

Special Issue Information

Dear Colleagues,

Obesity is associated with a reduced life expectancy, largely because obese individuals are at an increased risk of type 2 diabetes, cardiovascular disease, and several types of cancer. A great deal of interest has recently focused on the concept that “all obesity is not created equally.” Obese individuals without the metabolic abnormalities that commonly accompany excess adiposity, a condition known as metabolically healthy obesity (MHO), account for a substantial proportion of the obese adult population. Numerous possible mechanisms underlying MHO have been suggested, including adipose tissue distribution and inflammation. However, the prognostic value of MHO is controversial and considerably challenging.

Despite the debate about the clinical implications of MHO, it provides a unique human model system to study mechanisms linking the biological factors that promote weight gain and fat accumulations to obesity-related cardiometabolic complications. Although the exact mechanism underlying the MHO phenotype remains to be identified, several studies have looked at the differences between metabolically healthy and unhealthy obese individuals, including adipose tissue inflammation, immune regulation, and cellular energy metabolism.

Thereby, we invite colleagues to contribute to the present Special Issue with papers focused on a spectrum of MHO-related topics (basic and translational research), ranging from the molecular and cellular pathways of MHO to animal models to study MHO and novel pharmacological and molecular targets for the treatment of MHO.

Dr. Chang Hee Jung
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolically healthy obesity
  • obesity
  • metabolic syndrome
  • pathogenesis
  • molecular mechanisms
  • animal models
  • therapeutic targets
  • multi-omics

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 566 KiB  
Review
Pathogenesis, Murine Models, and Clinical Implications of Metabolically Healthy Obesity
by Yun Kyung Cho, Yoo La Lee and Chang Hee Jung
Int. J. Mol. Sci. 2022, 23(17), 9614; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms23179614 - 25 Aug 2022
Cited by 6 | Viewed by 3766
Abstract
Although obesity is commonly associated with numerous cardiometabolic pathologies, some people with obesity are resistant to detrimental effects of excess body fat, which constitutes a condition called “metabolically healthy obesity” (MHO). Metabolic features of MHO that distinguish it from metabolically unhealthy obesity (MUO) [...] Read more.
Although obesity is commonly associated with numerous cardiometabolic pathologies, some people with obesity are resistant to detrimental effects of excess body fat, which constitutes a condition called “metabolically healthy obesity” (MHO). Metabolic features of MHO that distinguish it from metabolically unhealthy obesity (MUO) include differences in the fat distribution, adipokine types, and levels of chronic inflammation. Murine models are available that mimic the phenotype of human MHO, with increased adiposity but preserved insulin sensitivity. Clinically, there is no established definition of MHO yet. Despite the lack of a uniform definition, most studies describe MHO as a particular case of obesity with no or only one metabolic syndrome components and lower levels of insulin resistance or inflammatory markers. Another clinical viewpoint is the dynamic and changing nature of MHO, which substantially impacts the clinical outcome. In this review, we explore the pathophysiology and some murine models of MHO. The definition, variability, and clinical implications of the MHO phenotype are also discussed. Understanding the characteristics that differentiate people with MHO from those with MUO can lead to new insights into the mechanisms behind obesity-related metabolic derangements and diseases. Full article
(This article belongs to the Special Issue Lipid and Metabolic Syndrome)
Show Figures

Figure 1

Back to TopTop